Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seybold, M. E.
Right arrow Articles by Lindstrom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seybold, M. E.
Right arrow Articles by Lindstrom, J. M.
NEUROLOGY 1981;31:778
© 1981 American Academy of Neurology

Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis

M. E. Seybold, M.D. and J. M. Lindstrom, Ph.D.

From the Neurology Service, San Diego Veterans Administration Medical Center and the Neurosciences and Surgery Departments, University of California, San Diego (Dr. Seybold), and the Salk Institute for Biological Studies (Dr. Lindstrom), San Diego, CA.

Antibodies to acetylcholine receptors (AChR-ab) were detected in a patient with myasthenia gravis (MG) and at much lower levels in her asymptomatic fraternal twin and one other asymptomatic sibling. These three carried the HLA-B8 allele, as did four other family members. In a previous study, we observed no AChR-ab in 175 non-MG patients. The occurrence of AChR-ab in 3 of 12 siblings suggests that all were affected by an unidentified pathologic factor acting on a favorable genetic background.

Address correspondence and reprint requests to Dr. Seybold, San Diego VA Medical Center, V-127, 3350 La Jolla Village Drive, San Diego, CA 92161.

This work was supported in part by the Los Angeles Chapter of the Myasthenia Gravis Foundation, Veterans Administration, Muscular Dystrophy Association, and National Institutes of Health (Grant No. NS11323).

Accepted for publication July 29, 1980.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.